Purpose: Four patients presented after cataract surgery with delayed-o
nset endophthalmitis caused by Acremonium kiliense with in vitro sensi
tivity to amphotericin B. In all patients, ocular infection was recalc
itrant to single-dose intravitreous amphotericin B injection. The auth
ors reviewed the management of endophthalmitis caused by A. kiliense a
nd presented treatment recommendations. Methods: The authors retrospec
tively evaluated a cluster of four patients with delayed-onset postope
rative endophthalmitis after phacoemulsification with posterior chambe
r intraocular lens implantation. All patients underwent vitreous sampl
ing, intravitreous injection of amphotericin B, and systemic administr
ation of fluconazole. Pars plana vitrectomy was performed in all patie
nts for management of either primary(1 eye) or persistent infection (3
eyes). Two patients with persistent infection also underwent surgical
explanation of their posterior chamber intraocular lens. Results: Wor
sening infection developed in three of three eyes that underwent vitir
eous aspiration with intravitreous injection of 5 mu g amphotericin B.
These patients subsequently responded to vitrectomy followed by addit
ional intravitreous amphotericin B injection. One eye underwent primar
y vitrectomy and intravitreous injection of 7.5 mu g amphotericin B. A
lthough treatment of the initial infection was successful, fungal kera
titis developed in this patient 3 months after presentation. Visual ou
tcome was variable, ranging from visual acuity of 20/25 to no light pe
rception with follow-up of 2 years. Epidemiologic investigation sugges
ted a common environmental source for the A. kiliense organisms. Concl
usions: Single-dose administration of intravitreous amphotericin a was
inadequate treatment for fungal endophthalmitis caused by A. kiliense
. Vitrectomy with repeated intravitreous administration of amphoterici
n B may be necessary to eradicate intraocular infection caused by this
organism.